European Multicenter and Open-Label Controlled Randomized Trial to Evaluate the Efficacy of Sequential Treatment With Tacrolimus-Rituximab Versus Steroids Plus Cyclophosphamide in Patients With Primary Membranous Nephropathy (The STARMEN Study)
Phase of Trial: Phase III
Latest Information Update: 14 Apr 2018
At a glance
- Drugs Rituximab (Primary) ; Tacrolimus (Primary) ; Cyclophosphamide; Methylprednisolone; Methylprednisolone
- Indications Membranous glomerulonephritis
- Focus Therapeutic Use
- Acronyms STARMEN
- 08 Sep 2015 Planned End Date changed from 1 Jan 2018 to 1 Apr 2019 as reported by ClinicalTrials.gov record.
- 08 Sep 2015 Planned primary completion date changed from 1 Jul 2017 to 1 Dec 2018 as reported by ClinicalTrials.gov record.
- 01 Jan 2015 Interim results of 23 subjects enrolled till April 2015 were published in the Clinical Kidney Journal.